Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' o
Target Price
The average target price of NXTMH.HE is 12 and suggests 6% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell